Cancer Center

EmailEmail    |   Bookmark Page Bookmark  |   RSS Feeds RSS  |   Print Page Print  

Lymphocyte Propagation Laboratory (LPL)


The Medical College of Wisconsin Cancer Center Lymphocyte Propagation Laboratory (LPL) is part of the Blood and Marrow Transplantation Program of the Medical College of Wisconsin.  This laboratory provides cellular therapy product processing for human clinical trials.  The laboratory primarily focuses on cellular therapy to improve the outcome of blood and marrow transplantation and the use of immunotherapy to combat human cancer. 

The laboratory is CAP accredited, CLIA certified and is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) for the testing and processing activities that are performed. 

Rates, Location & Hours


  • Pre-clinical consultation is performed at no-charge to the investigator.
  • The Lymphocyte Propagation Lab is located in the Froedtert Hospital Pavilion on the third floor.
  • The LPL is staffed from 7:30 AM to 5:00 PM, Monday through Friday. 
  • Contact Lab Director, Dr. Carolyn Taylor at 414.805.6145 for more information on location, hours and services.

Services


Consultation during early and mid-phase development

  • Identification of acceptable reagent and material sources
  • Assistance to prepare for FDA pre-IND meeting
  • Scale-up and/or transition to clinical grade product
  • Assist with writing of the chemistry, manufacturing, and controls (CMC) section of IND Application
  • Preparation of FDA compliant SOPs, work forms/batch records, and reports for product preparation and testing
  • Assist with the selection and validation of assays to ensure product safety, purity, and potency during phase I and II.
  • Production of products for clinical use and product storage
  • Release testing
  • Shipment to external sites
  • Prep and delivery of products for infusion
  • Post infusion immune monitoring with Flow Cytometry Shared Resource

Lab Director & Key Staff


Shared Resource Director, Carolyn A. Taylor, PhD is a transplant immunologist with extensive experience (>30 year) in transplant immunology and cellular therapy product processing.  She has been chosen for leadership roles in two professional societies, the International Society for Cellular Therapy (ISCT) and the American Society for Blood and Marrow Transplantation (ASBMT), of which she was a founding member and active participant in committee activities.

Fenlu Zhu, PhD, Research Scientist I, graduated from college with a Veterinary Science degree in China, went on to earn a Master’s Degree in Microbiology and Immunology at the same institution followed by a Doctoral Degree in 1994 in Beijing. Dr. Zhu focused on the immunology of hepatitis G virus through research scientist and post-doctoral fellowships in China then came to the US in 2000 to work on the immunology of hepatitis C virus at the BloodCenter of Wisconsin and in the Department of Pediatrics at the Medical College of Wisconsin until he joined the BMT Program Research Laboratory in 2009.   

Huiqing Xu, MD, MS, Senior Research Technologist I, earned her MD in medicine from Hebei University of Medical Sciences in China in 1991 and her Master’s Degree from Munich University of Technology in Germany in 2004.  She spent two years as a Research Associate in the Department of Pathology at the University of Massachusetts Medical School where she worked on projects related to EBV and influenza virus immunity, including eliciting T cell responses using viral peptides. 

Larry Luib MS, Cell Therapy Specialist LPL, has recently joined the LPL from a position at Fischer Scientific where he gained manufacturing experience with biological products, including GMP laboratory methods, product development, SOP development, product testing, regulatory and compliance activities.  He is currently undergoing training for the production of multi-virus CTL line production under the supervision of Dr. Zhu.  

Steve Konings, MS CPL and LPL Laboratory Manager, has held the position as manager of the BMT clinical laboratories, including the LPL and CPL, since 2004.  Prior to this he served from 1996 to 2004 as the senior technologist in the LPL and was largely responsible for the initial LPL projects using CMV T cell clones, retrovirus transduction of primary T cells, and the production of EBV-specific cell lines for clinical use.

Sarah M. Heidtke, BS CPL and LPL QA/QC Specialist, has held the role of QA/QC Specialist for the BMT laboratories since March 2011.  Prior to this she served as a Cell Therapy Specialist in the CPL from May 2006.  She is in charge of the Quality Management Program for the entire laboratory and has direct oversight of the Material Management System, which is critical to the production of products under GMP

webmaster@mcw.edu
© 2014 Medical College of Wisconsin
Page Updated 02/19/2013